Serum lactate dehydrogenase: a prognostic factor in pre-eclampsia


  • Meena Mehta Department of Obstetrics and Gynecology, RIMS, Ranchi, Jharkhand, India
  • Meetali Parashar Department of Obstetrics and Gynecology, RIMS, Ranchi, Jharkhand, India
  • Rajesh Kumar Department of Community Medicine, RIMS, Ranchi, Jharkhand, India



Maternal morbidity, Maternal mortality, Non severe pre eclampsia, Serum LDH, Severe pre eclampsia


Background: Pre eclampsia is responsible for significant maternal and perinatal morbidity and mortality worldwide .Serum LDH level is a useful biomarker for cellular injury which may reflect the severity of pre eclampsia and its level might be a guideline for management of patients. The aim of study was to find out the role of serum LDH in prediction of adverse outcome of pre eclampsia, severity of disease and occurrence of complications.

Methods: This prospective observational study was conducted in the department of Obstetrics and Gynecolog, RIMS, Ranchi, Jharkhand, India. A total of 300 cases were studied.150 cases were non severe preeclamptic and 150 cases were severe pre eclamptic patients. Serum LDH was done in both non severe and severe eclamptic patients .Data entry was done in Microsoft excel 2007. Results were analysed by chi square test.

Results: Higher LDH levels had significant correlation with high blood pressure as well as poor maternal and perinatal outcome.

Conclusions: High serum LDH level correlate well with the severity of disease and poor outcome in patients of pre eclampsia. Detection of high risk patients with increased levels of LDH mandate close monitoring and management to prevent maternal and fetal morbidity and mortality.


Jha N, Padhi M, Mishra A, Misra L, Nayak AK. Study on serum lactate dehydrogenase (LDH) as a biochemical marker for maternal and perinatal outcome in preeclampsia and eclampsia. Indian Obstet Gynaecol. 2015;5(4):6-12.

Gandhi M, Chavda R, Saini HB. Comparative study of serum LDH and uric acid in hypertensive verses normotensive pregnant women. Int J Biomed Res. 2015;6(1):25.

Jaiswar SP, Gupta A, Sachan R. Lactic dehydrogenase: a biochemical marker for pre eclampsia-eclampsia. J Obstet Gynaecol India. 2011;61(6):645-8.

Sreelatha. Estimation of serumlactate dehydrogenase and uric acid in preeclampsia. Int J Adv Case Reports. 2015;2(7):447-9.

Hak J, Gupta S. LDH Levels in pregnancy and its association with severity of the disease and feto-maternal outcome in pre-eclampsia and eclampsia. JK Science. 2015;17(3):110.

Umasatyasri Y, Vani I, Shamita P. Role of LDH (Lactate dehydrogenase) in preeclampsia - eclampsia as a prognostic marker : an observational study. Inte Arch Integrated Med. 2015;2(9):88-93.

Qublan HS, Ammarin V, Bataineh O. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe preeclampsia. Med Sci Monit. 2005;11(8):CR 393-7.

Aeziz R, Mahboob T. Relation between preeclampsia and cardiac enzymes. Arya Atherosclerosis J. 2008;4(1):29-38.

Sonagra AD, Dattatreya K, Jayaprakash M. Serum LDH, ALP and uric acid in hypertensive disorders of pregnancy. Int J Pharm Bio Sci. 2012;2(3):201-9.

Sarkar PD, Sogani S. Evaluation of serum lactate dehydrogenase and gama glutamyl transferase in preeclamptic pregnancy and its comparison with normal pregnancy in third trimester. Int J Res Med Sci. 2013;1(14):365-8.

Sonowal R. Significance of lactate dehydrogenase and aspartate transaminase as biochemical markers and as predictors of severity of pregnancy-induced hypertension and its complications. J Evidence Based Med Health. 2017;4(20):12-20.

Rukhsana A. Serum Lactate Dehydrogenase (LDH) level in severe preeclampsia. J Bangladesh Soc Physiol. 2015;10(2):71-5.

Hazari NR. Study of serum hepatic enzymes in preeclampsia. Int J Current Med Applied Sci. 2014;(1):1-8.

Sabiullah. Study of serum lactate dehydrogenase and uric acid in preeclampsia. Int J Pharma Res Biosci. 2015;4(3):160-6.

Agarwaal P. Serum LDH in preeclampsia and eclampsia and maternal outcomes. SJAMS. 2016;4(6C):2052-5.

Martin JN, May WL, Magann EF. Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynaecol. 1999;180:1407-14.

Catenzerite VA, Steinberg SM, Mosley CA. Severe preeclampsia with fulminant and extreme elevation of aspartate aminotrans ferase and lactate dehydrogenase levels. Am J Perinatol. 1995;12:310-3.

Demir SC, Evruke C, Ozgunen FT. Factors that influence morbidity, and mortality in severe preeclampsia, eclampsia and HELLP syndrome. Saudi Med J. 2006;27:1015-8.

He S, Bremme K, Kallner A, Blomback M. Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia; a predictor for birth of small for gestational age infants. Gynaecol Obstet Invest. 1995;39:234-8.






Original Research Articles